A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia
- DOI
- 10.1038/s41375-026-02976-5
- Published
- 2026-05-05
- Container
- Leukemia
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-02976-5,
title = {A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia},
author = {Sara M. A. Mohamed and Peter Schofield and Kathryn Evans and Karl-Heinz Friedrich and Daniel Christ and Narges Bayat and Richard B. Lock},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-02976-5},
url = {https://doi.org/10.1038/s41375-026-02976-5}
}RIS
TY - JOUR TI - A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia AU - Sara M. A. Mohamed AU - Peter Schofield AU - Kathryn Evans AU - Karl-Heinz Friedrich AU - Daniel Christ AU - Narges Bayat AU - Richard B. Lock PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-02976-5 UR - https://doi.org/10.1038/s41375-026-02976-5 ER -
APA
Mohamed, S. M. A., Schofield, P., Evans, K., Friedrich, K., Christ, D., Bayat, N., & Lock, R. B. (2026). A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia. Leukemia. https://doi.org/10.1038/s41375-026-02976-5
Source records
- crossref · retrieved 2026-09-25T21:02:40.780Z